{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:48:10Z","timestamp":1793836090029,"version":"4.6.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the occurrence of periaortic inflammation, including abscess formation, as a complication following endoleak repair after endovascular aortic repair.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective single-center study analyzed 88 EVAR revisions for endoleak treatment performed in 59 patients between 2015 and 2025. Patients underwent one to three revision procedures. Endoleaks were classified by type, and treatment was performed via transarterial access or direct sac puncture with a posterior\/translumbar access route. Embolization materials for type II endoleaks included n-butyl-2-cyanoacrylate, ethylene vinyl alcohol, and coils, while stent-graft extensions and transmural fixation were used for type I and III endoleaks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 59 patients, 38 (64.4%) underwent one revision, 13 (22.0%) two revisions, and 8 (13.6%) three revisions. Treated endoleaks included type I (19.3%), type II (77.3%), type III (2.3%), and combined type II\/III (1.1%). A total of 73 procedures (83.0%) were performed via transarterial access and 15 (17.0%) via direct sac puncture. Follow-up CT identified 6 cases of periaortic inflammation after type II endoleak repair, presenting with soft tissue mantle, fat stranding, or abscess formation. Symptom onset ranged from 33 to 108\u00a0days after the most recent intervention. No significant association was found between periaortic inflammation and access route or embolic material.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Periaortic inflammation and abscess formation are possible severe complications after endoleak repair following endovascular aortic repair. To date, these inflammatory changes have not been described systematically in the literature and warrant further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-026-00718-3","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:41:43Z","timestamp":1782528103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Periaortic inflammation after endoleak repair: a risk to watch"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4415-3013","authenticated-orcid":false,"given":"Marilia Bernadette","family":"Voigt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"B\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bahaaeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wagenpfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Isaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Christian","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian A.","family":"Luetkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Kupczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kuetting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"718_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jvs.2011.07.092","volume":"55","author":"TP Sarac","year":"2012","unstructured":"Sarac TP, Gibbons C, Vargas L, Liu J, Srivastava S, Bena J, et al. Long-term follow-up of type II endoleak embolization reveals the need for close surveillance. J Vasc Surg. 2012;55(1):33\u201340.","journal-title":"J Vasc Surg"},{"issue":"5","key":"718_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jvs.2011.10.131","volume":"55","author":"A Aziz","year":"2012","unstructured":"Aziz A, Menias CO, Sanchez LA, Picus D, Saad N, Rubin BG, et al. Outcomes of percutaneous endovascular intervention for type II endoleak with aneurysm expansion. J Vasc Surg. 2012;55(5):1263\u20137.","journal-title":"J Vasc Surg"},{"issue":"1","key":"718_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0741-5214(02)75467-0","volume":"38","author":"K Kasirajan","year":"2003","unstructured":"Kasirajan K, Matteson B, Marek JM, Langsfeld M. Technique and results of transfemoral superselective coil embolization of type II lumbar endoleak. J Vasc Surg. 2003;38(1):61\u20136.","journal-title":"J Vasc Surg"},{"issue":"6","key":"718_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ejvs.2018.06.009","volume":"56","author":"KHJ Ultee","year":"2018","unstructured":"Ultee KHJ, B\u00fcttner S, Huurman R, Gon\u00e7alves FB, Hoeks SE, Bramer WM, et al. Editor\u2019s choice \u2013 systematic review and meta-analysis of the outcome of treatment for type II endoleak following endovascular aneurysm repair. Eur J Vasc Endovasc Surg. 2018;56(6):794\u2013807.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"718_CR5","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.avsg.2016.01.036","volume":"35","author":"H Etienne","year":"2016","unstructured":"Etienne H, Touma J, Becquemin JP. Unusual acute onset of abdominal aortic endograft infection by Propionibacterium acnes after coil embolization for type II endoleak. Ann Vasc Surg. 2016;35:e9-204.","journal-title":"Ann Vasc Surg"},{"key":"718_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/acr-23-148","volume":"8","author":"N Robinson","year":"2024","unstructured":"Robinson N, Tallarita T, Beckermann J, Nijhawan V, McBride J, Saran N, et al. Infected stent graft and severe aortitis after transcaval glue embolization of type II endoleak: a case report. AME Case Rep. 2024;8:70.","journal-title":"AME Case Rep"},{"key":"718_CR7","doi-asserted-by":"publisher","first-page":"110140","DOI":"10.1016\/j.ijscr.2024.110140","volume":"122","author":"Q Bal\u00e9zeaux","year":"2024","unstructured":"Bal\u00e9zeaux Q, Leroux A, Krug B, Rondelet B, Belhaj A. Early and severe aortic endograft infection after percutaneous coil embolization of type 2 endoleak: a case report. Int J Surg Case Rep. 2024;122:110140.","journal-title":"Int J Surg Case Rep"},{"issue":"1","key":"718_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jvscit.2018.10.009","volume":"5","author":"B Li","year":"2019","unstructured":"Li B, Tan KT, MacDonald ME, Byrne J. Aortic graft infection with enteric organism after embolization of late type II endoleak. J Vasc Surg Cases Innov Tech. 2019;5(1):61\u20134.","journal-title":"J Vasc Surg Cases Innov Tech"},{"issue":"3","key":"718_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/CMR.00092-13","volume":"27","author":"Y Achermann","year":"2014","unstructured":"Achermann Y, Goldstein EJC, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27(3):419\u201340.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"718_CR10","doi-asserted-by":"publisher","first-page":"24-00143","DOI":"10.3400\/avd.oa.24-00143","volume":"18","author":"Y Takeuchi","year":"2025","unstructured":"Takeuchi Y, Morikage N, Sakamoto R, Mizoguchi T, Samura M, Harada T, et al. Clinical management of peri-aortitis following endovascular aortic repair for abdominal aortic aneurysm. Ann Vasc Dis. 2025;18(1):24\u201300143.","journal-title":"Ann Vasc Dis"},{"issue":"4","key":"718_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4174\/astr.2019.96.4.162","volume":"96","author":"YJ Suh","year":"2019","unstructured":"Suh YJ, Yu HW, Kim SJi, Choe JY, Park HJ, Choi JY, et al. Biocompatibility of n-butyl-2-cyanoacrylate (Histoacryl) in cervical structures of rats: prospective in vivo study. Ann Surg Treat Res. 2019;96(4):162\u20138.","journal-title":"Ann Surg Treat Res"},{"issue":"5","key":"718_CR12","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/00006123-199811000-00081","volume":"43","author":"Y Murayama","year":"1998","unstructured":"Murayama Y, Vi\u00f1uela F, Ulhoa A, Akiba Y, Duckwiler GR, Gobin YP, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery. 1998;43(5):1164\u201375.","journal-title":"Neurosurgery"},{"issue":"1","key":"718_CR13","first-page":"2024","volume":"19","author":"N Kidani","year":"2025","unstructured":"Kidani N, Hirotsune N. NBCA: basic knowledge. JNET J Neuroendovascular Ther. 2025;19(1):2024\u201355.","journal-title":"JNET J Neuroendovascular Ther"},{"issue":"1","key":"718_CR14","first-page":"13","volume":"21","author":"F Duffner","year":"2002","unstructured":"Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol. 2002;21(1):13\u20137.","journal-title":"Clin Neuropathol"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00718-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00718-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:41:44Z","timestamp":1782528104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00718-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00718-3","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study formal consent is not required.This article does not contain any studies with animals performed by any of the authors.This retrospective observational study was conducted with the approval of the local ethics committee under application number 303\/16, which granted a waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"For this type of study consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}